QGEN
Qiagen N.V.Healthcare · $9.2B market cap
Verdict
Share price
$44.75
close of Oct 3, 2026
Fair value
$33.41
Sticker Price
Payback Price
$13.36
buy price
QGEN is Overpriced: at $44.75 it trades 34% above its fair value of $33.41. Its buy price (Payback Price) is $13.36, 70% below today's price. Business quality is limited: none of the 5 key numbers clears the 10% bar.
How we valued it
Free Cash Flow. Sales grew -1% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.
Business quality
0 of 5 clear the 10% bar. What are the Big Five?
Follow QGEN
Get notified when it reaches its buy price of $13.36. Free.
Create a free accountAbout Qiagen N.V.
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary…
Medical - Diagnostics & Research
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works